FDA Approves Soliris® (Eculizumab) for the Treatment of Patients with
Soliris Start Form. Web soliris (eculizumab) physician information patient information * physician name: • have an infection or fever.
FDA Approves Soliris® (Eculizumab) for the Treatment of Patients with
Your doctor will discuss the ongoing timeline with you. Give you information and a patient. If a payer requires prior authorization and/or has a clinical policy, they may require proof of antibody status. 2) enroll in the soliris rems by. • have an infection or fever. Web enrollment in the soliris rems program and additional information are available by telephone: • are pregnant or plan to become pregnant. Web before you can receive soliris, your doctor must enroll in the soliris rems program; Eculizumab 300mg in 30ml dosage form: Discover if soliris is the right treatment option for your patients today.
• patients with a disease called paroxysmal nocturnal hemoglobinuria (pnh). • patients with a disease called paroxysmal nocturnal hemoglobinuria (pnh). Give you information and a patient. • are pregnant or plan to become pregnant. Discover if soliris is the right treatment option for your patients today. Web for patients 18 years of age and older, soliris therapy consists of: Web 1) review the soliris prescribing information, prescriber safety brochure, patient safety brochure and the patient safety card. *due to privacy regulations we will not be able to respond via fax with the. Counsel you about the risk of meningococcal infection; By completing your start form, you’re providing consent to alexion to collect your. Your doctor will discuss the ongoing timeline with you.
